Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma

被引：0
|
作者：
Habermann, T
Weller, E
Morrison, V
Gascoyne, R
Cassileth, P
Cohn, J
Dakhil, S
Woda, B
Fisher, R
Peterson, B
Horning, S
机构：
[1] ECOG, Med, Boston, MA USA
[2] ECOG, Stat, Boston, MA USA
[3] CALGB, Dept Med, Chicago, IL USA
[4] ECOG, Pathol, Boston, MA USA
[5] CALGB, Dept Pathol, Chicago, IL USA
[6] SWOG, DOM, San Antonio, TX USA
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
225
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [1] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, Thomas M.
    Weller, Edie A.
    Morrison, Vicki A.
    Gascoyne, Randy D.
    Cassileth, Peter A.
    Cohn, Jeffrey B.
    Dakhil, Shaker R.
    Woda, Bruce
    Fisher, Richard I.
    Peterson, Bruce A.
    Horning, Sandra J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3121 - 3127
  • [2] Rituximab-CHOP versus CHOP alone in patients with diffuse large B cell lymphoma.
    Cetiner, Mustafa
    Salepci, Taflan
    Atesoglu, Elif Birtas
    Gumus, Mahmut
    Guven, Aslihan
    Undar, Levent
    Tuglular, Tulin Firatli
    Bayik, Mahmut
    [J]. BLOOD, 2006, 108 (11) : 259B - 260B
  • [3] Rituximab-CHOP versus CHOP with or without maintenance rituximab in patients 60 years of age or older with diffuse large B-cell lymphoma (DLBCL): An update.
    Habermann, TM
    Weller, E
    Morrison, VA
    Cassileth, PA
    Cohn, J
    Dakhil, S
    Gascoyne, RD
    Woda, B
    Fisher, R
    Peterson, BA
    Horning, SJ
    [J]. BLOOD, 2004, 104 (11) : 40A - 40A
  • [4] CHOP chemotherapy plus rituximab compared with CHOP alone in diffuse large B-cell lymphoma patients
    Poddubnaya, I
    Osmanov, D
    Babicheva, L
    Falaleeva, N
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 177 - 177
  • [5] Rituximab and CHOP for elderly patients with diffuse large B-cell lymphoma
    Carol S. Portlock
    [J]. Current Oncology Reports, 2003, 5 (5) : 357 - 357
  • [6] Phase III trial of rituximab-CHOP (R-CHOP) vs. CHOP with a second randomization to maintenance rituximab (MR) or observation in patients 60 years of age and older with diffuse large B-cell lymphoma (DLBCL).
    Habermann, TM
    Weller, EA
    Morrison, VA
    Cassileth, PA
    Cohn, JB
    Dakhil, SR
    Gascoyne, RD
    Woda, B
    Fisher, RI
    Peterson, BA
    Horning, SJ
    [J]. BLOOD, 2003, 102 (11) : 6A - 6A
  • [7] Effect of Nutritional Status on Survival Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
    Park, Silvia
    Han, Boram
    Cho, Jae Won
    Woo, Sook-young
    Kim, Seonwoo
    Kim, Seok Jin
    Kim, Won Seog
    [J]. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2014, 66 (02): : 225 - 233
  • [8] CHOP chemotherapy plus rituximab compared with CHOP alone in patients with diffuse large B-cell lymphoma, from Indian subcontinent.
    Linga, Vijay Gandhi
    Digumarti, Raghunadharao
    Maddi, Rahul Narayan
    Goteke, Vamshi Krishna Reddy
    Gundeti, Sadashivudu
    Thota, Narender Kumar
    Coca, Pragnya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
    Li, Xueying
    Huang, He
    Xu, Bing
    Guo, Hongqiang
    Lin, Yingcheng
    Ye, Sheng
    Yi, Jiqun
    Li, Wenyu
    Wu, Xiangyuan
    Wang, Wei
    Zhang, Hongyu
    Xie, Derong
    Peng, Jiewen
    Cao, Yabing
    Pu, Xingxiang
    Guo, Chengcheng
    Hong, Huangming
    Wang, Zhao
    Fang, Xiaojie
    Zhou, Yong
    Lin, Suxia
    Liu, Qing
    Lin, Tongyu
    [J]. CANCER RESEARCH AND TREATMENT, 2019, 51 (03): : 919 - 932
  • [10] Rituximab, bevacizumab (avastin) and CHOP (RA-CHOP) for patients with diffuse large B-cell lymphoma (DLBCL).
    Ganjoo, KN
    Gordon, L
    Robertson, MJ
    Horning, SJ
    [J]. BLOOD, 2004, 104 (11) : 389A - 389A
12345